Novocure NVCR 深 滬
等待開盤 08-26 09:30:00 美东时间
11.70
-0.730
-5.87%
華盛通- 最 高12.42
- 今 開12.41
- 成交量 138.67万股
- 最 低 11.65
- 昨 收 12.43
- 總市值 12.99亿
- 52周最高 34.13
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 10.87
- 委 比 80.62%
- 總股本 1.11亿
- 歷史最高 232.76
- 量 比 1.17
- 振 幅 6.19%
- 歷史最低 5.95
- 每 手 1
- 風險率 4.97%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多最新！10款医疗器械进入创新通道
2025年8月5日，NMPA公布了创新医疗器械特别审查申请审查结果公示（2025年第7号），有10款产品进入创新通道。 1.产品名称：产前胎儿畸形...
08-06 11:56
Top 3 Health Care Stocks That May Explode In July
The most oversold stocks in the health care sector presents an opportunity to b...
07-28 18:52
美股周涨跌榜 | 本周飙升568%！Abivax S.A.新药III期研究成功；CRO股Medpace周涨超43%
本周飙升568%！生物技术公司Abivax S.A.溃疡性结肠炎口服药物III期研究成功；CRO股Medpace周涨超43%，Q2营收和EBITDA均超预期>>
07-26 10:23
Wells Fargo Downgrades NovoCure to Equal-Weight, Lowers Price Target to $14.5
Wells Fargo analyst Larry Biegelsen downgrades NovoCure (NASDAQ:NVCR) from Overweight to Equal-Weight and lowers the price target from $40 to $14.5.
07-25 21:22
NocoCure shares are trading lower. The company reported Q2 financial results.
NocoCure shares are trading lower. The company reported Q2 financial results.
07-24 23:05
Earnings Scheduled For July 24, 2025
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is likely to repo...
07-24 16:32
NovoCure Earnings Preview
NovoCure (NASDAQ:NVCR) is set to give its latest quarterly earnings report on T...
07-24 05:02
Ladenburg Thalmann Initiates Coverage On NovoCure with Buy Rating, Announces Price Target of $30
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on NovoCure (NASDAQ:NVCR) with a Buy rating and announces Price Target of $30.
07-08 20:17
美股大行评级 | 潜在涨幅205.56%！康托·菲茨杰拉德上调HIVE Digital Technologies目标价至5.5美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1145638202455883776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 康托·菲茨杰拉德：维持HIVE Digital Technologies(HIVE)"超配"评级，目标价从5美元升至5.5美元</p> <p>• BTIG：维持Theravance Biopharma(TBPH)"买入"评
06-28 08:37
Demystifying NovoCure: Insights From 4 Analyst Reviews
Ratings for NovoCure (NASDAQ:NVCR) were provided by 4 analysts in the past thre...
06-28 02:01
